General classes of vaccines An induced mobilization of the immune response for the purpose of therapeutic benefit. Preventative: infectious agents Therapeutic:

Slides:

Advertisements

Similar presentations

Chapter15 B cell mediated immune response. B cells mediated immune response Humoral immunity(HI) or antibody mediated immunity: The total immunological.

Advertisements

Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination Peter L. Stern Journal of Clinical Virology, 2005.

DNA Vaccination Anneline Nansen

Reminders Midterm test on Tuesday Review session Saturday 4-6 PM, here. Reading: Chapters 3, 5, 6,

Lecture outline Capture of antigens from sites of entry and display of antigens to T cells Function of MHC molecules as the peptide display molecules of.

Immunoprophylaxis (prophylactic immunization). Immunoprophylaxis Types of immunization Immunoglobulins and vaccines Strategies in vaccine preparation.

Defenses Against Infection 1. Innate responses (humoral and cellular) 2. Immunity to intracellular pathogens NK cells, control of Th1/Th2 responses 3.

Vaccines Robert Beatty MCB150. Passive vs Active Immunity  Passive immunization transfer of antibodies  Vaccines are active immunizations (mimic natural.

Lecture 11-Activation of naïve T cells Naïve T cells are activated in lymph nodes and spleen. Dendritic cells are key antigen presenting cells for naïve.

Immunotherapy K J. Goodrum Immunotherapies Vaccines (toxoid, attenuated live, killed cell vaccines, subcellular, DNA, peptide) Adjuvants (nonspecific.

Manipulation of the Immune Response Chapter 14

T cell-mediated immunity Chapter 8

Antigen Presentation and MHC Molecules

Adaptive Defenses T Lymphocytes T lymphocytes constitute the "cellular" arm of acquired/specific immunity T lymphocytes play a central role in controlling.

Lecture outline Capture of antigens from sites of entry and display of antigens to T cells Function of MHC molecules as the peptide display molecules of.

By Aizaz Khan. Maurice Hilleman discover measle vaccine. Maurice Hilleman Maurice Hilleman's measles vaccine is estimated to prevent 1 million deaths.

Designing CD8+ T cell vaccines: It`s not rocket science (yet) Jonathan W Yewdell Current Opinion in Immunology But the review is....

CRITICAL FACTORS IN DETERMINING THE ANTIGENIC COMPOSITION OF A VACCINE.

Novel strategies for prevention and treatment of HIV infection Prasit Faipenkhong Pairoaj Vonghathaipaisarn Rodjana Chunhabundit Zhang Jianjun.

STATENS SERUM INSTITUT DNA Vaccination Anneline Nansen Department of Infectious Disease Immunology Statens Serum Institut (SSI)

Active and passive immunization Immunity to infectious microorganisms: Immunity to infectious microorganisms: 1- Active immunization *** natural processes.

Immunology of Vaccines

Phagocyte. B cells Receptor B Cell Naïve B cell B cells and antibodies daughter cells produce antibodies phagocyte consumes an antibody coated virus.

Specific Resistance = Immunity

Immune System Chris Schneider. Immune System Function The purpose of the immune system is to keep infectious microorganisms, such as certain bacteria,

Viral Evasion Strategies Supplement to Chapter 8 Finlay and McFadden Cell. 124:

Adaptive/Acquired Immunity

Adaptive immunity 2440 spring lecture #7 5/27/10.

Infectious diseases Tissue transplantation Elimination of tumors Autoimmune diseases Gatekeeper function Sensing pathogens Priming adaptive immune responses.

Lecture #10 Aims Describe T cell maturation and be able to differentiate naïve and effector T cells. Differentiate the development and functions of Th1.

Dendritic Cell and its Role in Adaptive Immunity and Cancer Immunotherapy Amna Muhammad Ph. D scholar Biochemistry 1.

Vaccines: A Molecular View

Immunology 2 nd Med 2009 Some revision points Con Feighery.

14. Immunodiagnosis, Immunotherapy & Vaccination 王家鑫， MD College of Veterinary Medicine.

PROFESSIONAL ANTIGEN PRESENTING CELLS

THE IMMUNE RESPONSES TO VIRUSES

Inducing and expanding regulatory T cell populations by foreign antigen Karsten Kretschmer NATURE IMMUNOLOGY 2005; 6:1219.

ANTIGEN PRESENTING CELLS. Professional antigen presenting cells Definition: Antigen-presenting cells (APCs) are a heterogeneous group of immune cells.

Antigen presentation to T cells Zheng W. Chen, M.D., Ph.D.

Basic Immunology University of Tabuk Faculty of Applied Medical Science Department of Medical Laboratory Technology Mr.AYMAN.S.YOUSIF MSc.Medical Microbiology.

T -lymphocytes T cell receptor T – cytotoxic (CD8) cells

Making Vaccines. Effective Vaccines Have low levels of side effects or toxicity. Protect against exposure to natural, or wild forms of the pathogen. Should.

HOST RESPONSE TO VIRAL INFECTIONS. Flu Attack! How A Virus Invades Your Body.

Interferons Induction of synthesis Induction of antiviral activity Antiviral activities induced by interferons  and  Antiviral activities induced by.

T Cells Lacey Jeong. What is a T Cell?? Thymus cell – produced and processed by the thymus gland Lymphocyte (white blood cell) – protect body from infection.

Vaccine Introduction Fahareen-Binta-Mosharraf MNS.

Vaccine; To be effective  Must stimulate as many of the body's defence mechanisms as possible.  It is not necessary to get 100% uptake of vaccine in.

Chapter 16 Immunizations and Immunity. Amazing Fact “An estimated 2.1 million people around the world died in 2002 of diseases preventable by widely used.

Gamma Delta (gd) T Cells

Lecture Outline Antigens Definition Exogenous Endogenous

Lecture 16 Cellular Cooperation and Antigen Recognition

Antigen Presentation and MHC Molecules

Immunology Lecture 4 Development of B and T lymphocytes

Adaptive immunity antigen recognition Y Y Y Y Y Y Y Y Y invading

Chapter 7-Vaccines Vaccination Current and future vaccines

Thymocyte development summary

Effector mechanisms of humoral immunity

CELL-MEDIATED IMMUNITY RAHUL KUMAR LOHANA 2K16/MB/50 INSTITUTE OF MICROBIOLOGY UNIVERSITY OF SINDH, JAMSHORO.

Foreign agenses, molecules, cells

and CHAPTER 6 Major Histocompatibility Complex (MHC) Molecules

Advances in Specific Immunotherapy for Prostate Cancer

The body’s defenders.

Adaptive Immune System

Designing Vaccines Based on Biology of Human Dendritic Cell Subsets

Th1 and Th2 immune responses

SPECIFIC IMMUNE RESPONSE

T Cell Activation and proliferation

Vaccines for Lung Cancer

Presentation transcript:

General classes of vaccines An induced mobilization of the immune response for the purpose of therapeutic benefit. Preventative: infectious agents Therapeutic: cancer

General classes of vaccines Antibody response CD4+ T cells, B cells MHC class II-dependent Cellular response cytotoxic CD8+ T cells, NK cells MHC class I-dependent

Classical success: polio virus vaccine: killed/attenuated virus injected (Salk) oral (Sabin) oral route of infection initial replication in GI tract

Paroxysmal success: influenza killed/attenuated virus, protein antibody to viral spike glycoprotein (hemagglutinin, HA) confers protection infects via airway epithelial/systemic replication HA genetic drift subverts antibody

Unmitigated failure: HIV killed/attenuated virus recombinant envelope glycoprotein poor protection, cumbersome trials infects via anal/vaginal epithelia replication/residence in immune cells >80 million infected individuals/victims 3.1 million new cases/year in Africa alone

Why have HIV vaccines failed? gp120 genetic drift subverts antibody virus is rarely extracellular wrong viral component, wrong delivery? underdesigned? or…overdesigned?

Typical antigen formulations peptides bound to carriers (adjuvants) recombinant proteins killed or attenuated virus/bacteria DNA or mRNA encoding protein antigen

Typical vaccine delivery vehicles injection in adjuvant (skin, muscle) oral, nasal recombinant or synthetic viral vector transformed microbial vector

Engineering rational vaccines understand biology of target understand biology of response bioengineering

Production of MHC class I & II-peptide complexes Virus-encoded proteins

“Cross presentation” of exogenous antigens on MHC class I: CD8 responses to extracellular agents

Dendritic cells initiate antigen- specific immune responses most efficient of all APCs high MHC class I, II & costimulators efficient cross presentation stimulate naïve T cells (CD4, CD8) initiate Ag-specific immune responses All immunization strategies must target DCs

Immature: antigen capture Mature: antigen presentation

immature DCmature DC Multiple inducers of DC maturation various T cell responses Microbial products / TLR ligands Viral products Inflammatory cytokines Signaling receptors

Targeting DCs to elicit immunity: engineering requirements The optimal delivery device… will be targetable to selected DC populations can be coupled to DC maturation agents (microbial, inflammatory, other?) can accomodate any type of antigen permits intracellular targeting (cross-presentation from cytosol favors cytotoxic T cell responses) traceable (does it reach DCs, nodes?) modular (permits efficient, small-scale trials) synthetic, stable, orally available for global use